Status:

COMPLETED

AST-120 Used to Treat Mild Hepatic Encephalopathy

Lead Sponsor:

Ocera Therapeutics

Conditions:

Mild Hepatic Encephalopathy

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine whether AST-120 is safe and effective in the treatment of mild hepatic encephalopathy.

Eligibility Criteria

Inclusion

  • Confirmed cirrhosis of any cause
  • Abnormal RBANS global summary score
  • Grade 0 or 1 hepatic encephalopathy by West-Haven Scale
  • MELD score \< or = 25
  • Females must be postmenopausal, surgically incapable of bearing children or practicing a reliable method of birth control

Exclusion

  • Previous participation in any trial involving AST-120
  • History of TIPS or surgically created portocaval shunt
  • Treatment for overt HE within the past 3 months
  • Use of lactulose, rifaximin, neomycin or other antibiotics in the past 7 days
  • Active alcohol abuse
  • Psychosis or organic brain syndromes due to alcohol or other causes
  • Use of interferon and sedating or cognition-altering drugs
  • Undergoing chemotherapy or radiotherapy for the treatment of cancer
  • Active GI bleeding within the past 3 months
  • Presence of an active infection
  • Presence of signs and symptoms of severe dehydration
  • Other major physical or major psychiatric illness within the past 6 months
  • Pregnant, breast feeding, or planning to become pregnant during the study
  • Using hormonal contraception as the only method of birth control

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

148 Patients enrolled

Trial Details

Trial ID

NCT00867698

Start Date

March 1 2009

End Date

June 1 2010

Last Update

June 18 2014

Active Locations (38)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (38 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

Mayo Clinic Arizona

Phoenix, Arizona, United States, 85054

3

UCSF - Fresno Community Regional Medical Center

Fresno, California, United States, 93721

4

UCSD Medical Center

La Jolla, California, United States, 92161

AST-120 Used to Treat Mild Hepatic Encephalopathy | DecenTrialz